Samuels Replaces Smith As BGMA Chief
Warwick Smith Steps Down After 25 Years As Head Of UK Association
Executive Summary
Warwick Smith has stepped down as head of the British Generic Manufacturers Association and British Biosimilars Association, to be replaced by Mark Samuels as CEO.
You may also be interested in...
New BGMA Chief Battles Twin Pressures Of COVID And Brexit
When Mark Samuels took over leadership of the BGMA earlier this year, he was immediately forced to grapple with the twin pressures of Brexit and the COVID-19 pandemic. However, he tells Generics Bulletin in an exclusive interview, the UK off-patent industry has succeeded in maintaining supply against this difficult backdrop and deserves a more coherent government strategy to support the sector.
UK Could Become ‘World Leader’ On Biosimilar Regulation
The UK is putting itself in a position to play a leading role in global biosimilars regulation, thanks to a proposed new registration pathway that will not require comparative efficacy data, delegates to a Westminster Health Forum online conference heard.
UK Could Become ‘World Leader’ On Biosimilar Regulation
The UK is putting itself in a position to play a leading role in global biosimilars regulation, thanks to a proposed new registration pathway that will not require comparative efficacy data, delegates to a Westminster Health Forum online conference heard earlier today.